Clinical Trial
doi: 10.1007/978-3-642-79952-5_10.
Treatment of diffuse leptomeningeal malignancy by intrathecal injection of 131I radioimmunoconjugates
Affiliations
- PMID: 8722425
- DOI: 10.1007/978-3-642-79952-5_10
Item in Clipboard
Clinical Trial
Treatment of diffuse leptomeningeal malignancy by intrathecal injection of 131I radioimmunoconjugates
Recent Results Cancer Res.
1996.
No abstract available
Similar articles
-
The treatment of patients with recurrent malignant gliomas with intratumoral radioimmunoconjugates.Recent Results Cancer Res. 1996;141:159-75. doi: 10.1007/978-3-642-79952-5_11. Recent Results Cancer Res. 1996. PMID: 8722426 Clinical Trial. No abstract available.
-
Minimal residual disease: a target for radioimmunotherapy with 131I-labeled monoclonal antibodies? Some dosimetric considerations.Recent Results Cancer Res. 1996;141:67-75. doi: 10.1007/978-3-642-79952-5_5. Recent Results Cancer Res. 1996. PMID: 8722420 No abstract available.
-
Immunoreactivity, pharmacokinetics and bone marrow dosimetry of intrathecal radioimmunoconjugates.Int J Cancer. 1992 Aug 19;52(1):38-43. doi: 10.1002/ijc.2910520109. Int J Cancer. 1992. PMID: 1500225
-
Radioimmunotherapy with 131I-rituximab: what we know and what we don't know.Cancer Biother Radiopharm. 2003 Aug;18(4):489-95. doi: 10.1089/108497803322287565. Cancer Biother Radiopharm. 2003. PMID: 14503943 Review. No abstract available.
-
The clinical importance of dosimetry in radioimmunotherapy with tositumomab and iodine I 131 tositumomab.Semin Oncol. 2003 Apr;30(2 Suppl 4):31-8. doi: 10.1053/sonc.2003.23799. Semin Oncol. 2003. PMID: 12728405 Review.
Cited by
-
Cerebrospinal fluid-administered therapies for leptomeningeal metastases from solid tumors.Future Oncol. 2023 Aug;19(26):1801-1807. doi: 10.2217/fon-2022-0926. Epub 2023 Sep 22. Future Oncol. 2023. PMID: 37737023 Free PMC article. Review.
-
Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis.Curr Oncol Rep. 2003 Jan;5(1):29-40. doi: 10.1007/s11912-003-0084-9. Curr Oncol Rep. 2003. PMID: 12493148 Review.